Ferm Solutions, Inc.; Filing of Food Additive Petition (Animal Use); Virginiamycin, 62545-62546 [2010-25522]
Download as PDF
<![CDATA[
62545
Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices
respondents time at the rate of $17.00
per hour and physician time at the rate
of $75.00 per hour. There are no Capital
Costs to report. There are no Operating
or Maintenance Costs to report.
TABLE A.12.1 ESTIMATES OF HOUR BURDEN
Estimated
number of
respondents
Type of respondents
Estimated
number of
responses per
respondent
Average
burden hours
per response
Participants .........................................................................................................
Physician (or coroner) (for CHD) .......................................................................
Physician (for heart failure) ................................................................................
Participants’ next of kin ......................................................................................
10,933
420
920
400
3
1
1
1
0.6165
0.1667
0.0833
0.1667
Totals ..........................................................................................................
12,673
........................
........................
Estimated
total annual
burden hours
requested
20220.6.
70.
76.6.
66.7.
20433.9 or
20434.
Note: Reported and calculated numbers differ slightly due to rounding.
srobinson on DSKHWCL6B1PROD with NOTICES
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
For Further Information: To request
more information on the proposed
project or to obtain a copy of the data
collection plans and instruments,
contact Dr. Hanyu Ni, Project Officer,
NIH, NHLBI, 6701 Rockledge Drive,
MSC 7934, Bethesda, MD 20892–7934,
or call non-toll-free number (301) 435–
0448 or E-mail your request, including
your address to:
NiHanyu@nhlbi.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60-days of the date of
this publication.
Dated: October 6, 2010.
Suzanne Freeman,
NHLBI Project Clearance Liaison, National
Institutes of Health.
Michael Lauer,
Director, DCVS, National Institutes of Health.
[FR Doc. 2010–25641 Filed 10–8–10; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
17:43 Oct 08, 2010
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–F–0510]
Ferm Solutions, Inc.; Filing of Food
Additive Petition (Animal Use);
Virginiamycin
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that Ferm Solutions, Inc. has filed a
petition proposing that the food additive
regulations be amended to provide for
the safe use of virginiamycin as an
antimicrobial processing aid in fuelethanol fermentations with respect to its
consequent presence in by-product
distiller grains used as an animal feed
or feed ingredient.
DATES: Submit either electronic or
written comments on the petitioner’s
environmental assessment by November
12, 2010.
ADDRESSES: Submit electronic
comments to: https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Isabel W. Pocurull, Center for Veterinary
Medicine, Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240–453–6853, email: isabel.pocurull@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
Federal Food, Drug, and Cosmetic Act
(section 409(b)(5) (21 U.S.C. 348(b)(5)),
notice is given that a food additive
petition (FAP 2264) has been filed by
Ferm Solutions, Inc., PO Box 203,
Danville, KY 40422. The petition
SUMMARY:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
proposes to amend the food additive
regulations in part 573 Food Additives
Permitted in Feed and Drinking Water of
Animals (21 CFR part 573) to provide
for the safe use of virginiamycin as an
antimicrobial processing aid in fuelethanol fermentations with respect to its
consequent presence in by-product
distiller grains used as an animal feed
or feed ingredient.
The potential environmental impact
of this action is being reviewed. To
encourage public participation
consistent with regulations issued under
the National Environmental Policy Act
(40 CFR 1501.4(b)), the agency is
placing the environmental assessment
submitted with the petition that is the
subject of this notice on public display
at the Division of Dockets Management
(see DATES and ADDRESSES) for public
review and comment.
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) either electronic or written
comments regarding this document. It is
only necessary to send one set of
comments. It is no longer necessary to
send two copies of mailed comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
FDA will also place on public display
any amendments to, or comments on,
the petitioner’s environmental
assessment without further
announcement in the Federal Register.
If, based on its review, the agency finds
that an environmental impact statement
is not required and this petition results
in a regulation, the notice of availability
of the agency’s finding of no significant
impact and the evidence supporting that
finding will be published with the
regulation in the Federal Register in
accordance with 21 CFR 25.51(b).
E:\FR\FM\12OCN1.SGM
12OCN1
62546
Federal Register / Vol. 75, No. 196 / Tuesday, October 12, 2010 / Notices
Dated: October 4, 2010.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
srobinson on DSKHWCL6B1PROD with NOTICES
Name of Committee: National Institute on
Deafness and Other Communication
Disorders, Special Emphasis Panel, CDRC
Conflicts.
Date: October 26, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Christine A. Livingston,
PhD, Scientific Review Officer, Division of
Extramural Activities, National Institutes of
Health/NIDCD, 6120 Executive Blvd.—MSC
7180, Bethesda, MD 20892, (301) 496–8683,
livingsc@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: October 5, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–25604 Filed 10–8–10; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
[FR Doc. 2010–25522 Filed 10–8–10; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group, Acquired Immunodeficiency
Syndrome Research Review Committee.
Date: November 8, 2010.
Time: 10 a.m. to 5 p.m. To review and
evaluate grant applications.
Agenda: National Institutes of Health.
Place: 6700B Rockledge Drive, Bethesda,
MD 20817 (Telephone Conference Call).
Contact Person: Sujata Vijh, PhD, Scientific
Review Officer, Scientific Review Program,
DEA/NIAID/NIH, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, 301–
594–0985, vijhs@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, HIV Vaccine Research and
Design (HIVRAD) Program.
Date: November 9–10, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Betty Poon, PhD, Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 20892–7616, 301–402–
6891, poonb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 5, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–25608 Filed 10–8–10; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
17:43 Oct 08, 2010
Jkt 223001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: NIDCR Special Grants
Review Committee, NIDCR Special Grants
Review Committee: Review of F, K, and R03,
Applications.
Date: October 21–22, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Palace Hotel, 2 New Montgomery,
San Francisco, CA 94105.
Contact Person: Raj K. Krishnaraju, PhD,
MS, Scientific Review Officer, Scientific
Review Branch, National Inst of Dental &
Craniofacial Research, National Institutes of
Health, 45 Center Dr. Rm 4AN 32J, Bethesda,
MD 20892, 301–594–4864,
kkrishna@nidcr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the urgent
need to meet timing limitations imposed by
the intramural research review cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: October 5, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–25611 Filed 10–8–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
E:\FR\FM\12OCN1.SGM
12OCN1
]]>Agencies
[Federal Register Volume 75, Number 196 (Tuesday, October 12, 2010)]
[Notices]
[Pages 62545-62546]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-25522]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-F-0510]
Ferm Solutions, Inc.; Filing of Food Additive Petition (Animal
Use); Virginiamycin
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that Ferm
Solutions, Inc. has filed a petition proposing that the food additive
regulations be amended to provide for the safe use of virginiamycin as
an antimicrobial processing aid in fuel-ethanol fermentations with
respect to its consequent presence in by-product distiller grains used
as an animal feed or feed ingredient.
DATES: Submit either electronic or written comments on the petitioner's
environmental assessment by November 12, 2010.
ADDRESSES: Submit electronic comments to: https://www.regulations.gov.
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Isabel W. Pocurull, Center for
Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240-453-6853, e-mail: isabel.pocurull@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (section 409(b)(5) (21 U.S.C. 348(b)(5)), notice is given that a
food additive petition (FAP 2264) has been filed by Ferm Solutions,
Inc., PO Box 203, Danville, KY 40422. The petition proposes to amend
the food additive regulations in part 573 Food Additives Permitted in
Feed and Drinking Water of Animals (21 CFR part 573) to provide for the
safe use of virginiamycin as an antimicrobial processing aid in fuel-
ethanol fermentations with respect to its consequent presence in by-
product distiller grains used as an animal feed or feed ingredient.
The potential environmental impact of this action is being
reviewed. To encourage public participation consistent with regulations
issued under the National Environmental Policy Act (40 CFR 1501.4(b)),
the agency is placing the environmental assessment submitted with the
petition that is the subject of this notice on public display at the
Division of Dockets Management (see DATES and ADDRESSES) for public
review and comment.
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) either electronic or written comments regarding this
document. It is only necessary to send one set of comments. It is no
longer necessary to send two copies of mailed comments. Identify
comments with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday. FDA will
also place on public display any amendments to, or comments on, the
petitioner's environmental assessment without further announcement in
the Federal Register. If, based on its review, the agency finds that an
environmental impact statement is not required and this petition
results in a regulation, the notice of availability of the agency's
finding of no significant impact and the evidence supporting that
finding will be published with the regulation in the Federal Register
in accordance with 21 CFR 25.51(b).
[[Page 62546]]
Dated: October 4, 2010.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
[FR Doc. 2010-25522 Filed 10-8-10; 8:45 am]
BILLING CODE 4160-01-P
